Method for the treatment of neurological and neuropsychological disorders
CA 2689012 A1 · Owner: Kruber, Susanne · Inventors: Von Hoersten, Stephan; Nguyen, Huu Phuc; Demuth, Hans-Ulrich
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention discloses a method for therapeutically treating an animal, including , a human, for psychosomatic depressive and neuropsychiatric diseases such as , anxiety, depression, insomnia schizophrenia, epilepsy, spasm and chronic pain. Administration of a , suitable DP IV inhibitor leads as a causal consequence to a reduced degradation of the , neuropeptide Y (NPY) in the brain of mammals. Such treatment will result in a reduction or delay , in the decrease of the concentration of functionally active neuronal NPY (1- 36). As a , consequence of the resulting enhanced stability of the endogenous NPY (1-36) NPY activity is , prolonged thereby resulting among other things in …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 29, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 29, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 29, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.